Company Overview
American Healthcare Capital is pleased to be the exclusive representative of a growing, integrated interventional pain clinic and ambulatory surgery center in Southern California. This integrated interventional pain clinic and ambulatory surgery center (ASC) serves a large Medicare-eligible and seasonal population in an affluent, growing Southern California market, where it has a strong reputation. The platform includes professional services, facility-based pain procedures, and a recently launched durable medical equipment (DME) bracing program. The ASC offers one operating room plus additional procedure space in a high-quality facility with meaningful unused growth capacity.
Growth and Financial Momentum
Revenue grew 94% from FY2024 to FY2025 and 28% in H1 2026 versus H1 2025, with operations profitable every month since February 2026. Consolidated net revenue was $5.06 million for the TTM ended June 30, 2026, $4.52 million in FY2025, and $2.44 million in H1 2026. Management’s adjusted TTM EBITDA of approximately $377,000 incorporates approximately $233,000 of buyer-specific cost efficiencies and other proposed adjustments.
Clinical Team and Continuity
One employed physician, one physician assistant, and one nurse practitioner support current operations, with a second physician in the process of joining to support significant growth. The clinicians intend to remain. The selling principals are non-clinicians and generate no clinical collections, so their departure does not put owner-generated clinical revenue at risk.
Growth Opportunity
Existing clinic space and unused ASC capacity support additional physician volume, DME and neuromodulation expansion, referral development, and payor contract optimization. Management estimates next-twelve-month revenue of $5.8 million–$6.5 million and forward annualized EBITDA scenarios of $600,000 base, $900,000 expected, and $1.2 million+ target.
Asking Price and Valuation
Price to be determined. The sellers prefer a strategic buyer for a full exit and are flexible on structure. The platform will be delivered cash-free and debt-free closing, with no complicated physician syndication or minority-owner buyout process. Leases are secured through 2030 for the ASC and 2032 for the clinic. Pre-closing accounts receivable are retained by the seller; no owned real estate is included. Final valuation and terms will be negotiated.